About Windward Bio
Windward Bio is a clinical-stage biotechnology company with deep discovery, development, and commercial expertise, developing ultra-long-acting antibodies for patients with serious respiratory and dermatologic diseases, including asthma, COPD, and atopic dermatitis. The company is advancing a pipeline of potentially differentiated biologics targeting clinically validated molecular pathways, with the goal of improving clinical outcomes while reducing treatment burden through less frequent dosing. Windward Bio is headquartered in Basel, Switzerland, with operations in the United States.